Calumet Statistics
Total Valuation
Calumet has a market cap or net worth of $5.19 billion. The enterprise value is $7.44 billion.
| Market Cap | 5.19B |
| Enterprise Value | 7.44B |
Important Dates
The next estimated earnings date is Friday, November 6, 2026, before market open.
| Earnings Date | Nov 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Calumet has 87.90 million shares outstanding. The number of shares has increased by 1.02% in one year.
| Current Share Class | 87.90M |
| Shares Outstanding | 87.90M |
| Shares Change (YoY) | +1.02% |
| Shares Change (QoQ) | +0.68% |
| Owned by Insiders (%) | 3.21% |
| Owned by Institutions (%) | 45.36% |
| Float | 59.09M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 18.35 |
| PS Ratio | 1.13 |
| Forward PS | 1.09 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 70.56 |
| P/OCF Ratio | 35.50 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 89.36, with an EV/FCF ratio of 101.28.
| EV / Earnings | n/a |
| EV / Sales | 1.62 |
| EV / EBITDA | 89.36 |
| EV / EBIT | n/a |
| EV / FCF | 101.28 |
Financial Position
The company has a current ratio of 0.84
| Current Ratio | 0.84 |
| Quick Ratio | 0.43 |
| Debt / Equity | n/a |
| Debt / EBITDA | 28.43 |
| Debt / FCF | 32.22 |
| Interest Coverage | -0.28 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -1.32% |
| Return on Invested Capital (ROIC) | -3.48% |
| Return on Capital Employed (ROCE) | -3.71% |
| Weighted Average Cost of Capital (WACC) | 7.80% |
| Revenue Per Employee | $2.98M |
| Profits Per Employee | -$88,831 |
| Employee Count | 1,540 |
| Asset Turnover | 1.65 |
| Inventory Turnover | 10.80 |
Taxes
| Income Tax | -135.30M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +214.42% in the last 52 weeks. The beta is 0.72, so Calumet's price volatility has been lower than the market average.
| Beta (5Y) | 0.72 |
| 52-Week Price Change | +214.42% |
| 50-Day Moving Average | 47.36 |
| 200-Day Moving Average | 33.36 |
| Relative Strength Index (RSI) | 76.55 |
| Average Volume (20 Days) | 1,298,103 |
Short Selling Information
The latest short interest is 3.68 million, so 4.18% of the outstanding shares have been sold short.
| Short Interest | 3.68M |
| Short Previous Month | 3.56M |
| Short % of Shares Out | 4.18% |
| Short % of Float | 6.22% |
| Short Ratio (days to cover) | 3.00 |
Income Statement
In the last 12 months, Calumet had revenue of $4.59 billion and -$136.80 million in losses. Loss per share was -$1.57.
| Revenue | 4.59B |
| Gross Profit | 317.80M |
| Operating Income | -58.80M |
| Pretax Income | -272.10M |
| Net Income | -136.80M |
| EBITDA | 83.30M |
| EBIT | -58.80M |
| Loss Per Share | -$1.57 |
Balance Sheet
The company has $109.80 million in cash and $2.37 billion in debt, with a net cash position of -$2.26 billion or -$25.69 per share.
| Cash & Cash Equivalents | 109.80M |
| Total Debt | 2.37B |
| Net Cash | -2.26B |
| Net Cash Per Share | -$25.69 |
| Equity (Book Value) | -886.50M |
| Book Value Per Share | -12.94 |
| Working Capital | -194.00M |
Cash Flow
In the last 12 months, operating cash flow was $146.10 million and capital expenditures -$72.60 million, giving a free cash flow of $73.50 million.
| Operating Cash Flow | 146.10M |
| Capital Expenditures | -72.60M |
| Depreciation & Amortization | 142.10M |
| Net Borrowing | -92.60M |
| Free Cash Flow | 73.50M |
| FCF Per Share | $0.84 |
Margins
Gross margin is 6.92%, with operating and profit margins of -1.28% and -2.98%.
| Gross Margin | 6.92% |
| Operating Margin | -1.28% |
| Pretax Margin | -5.93% |
| Profit Margin | -2.98% |
| EBITDA Margin | 1.81% |
| EBIT Margin | -1.28% |
| FCF Margin | 1.60% |
Dividends & Yields
Calumet does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -1.02% |
| Shareholder Yield | -1.02% |
| Earnings Yield | -2.64% |
| FCF Yield | 1.42% |
Analyst Forecast
The average price target for Calumet is $53.40, which is -9.49% lower than the current price. The consensus rating is "Buy".
| Price Target | $53.40 |
| Price Target Difference | -9.49% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (3Y) | 6.61% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Calumet has an Altman Z-Score of 0.83 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.83 |
| Piotroski F-Score | 5 |